Genetic tissue-specific deletions of MAP4K4 in macrophages as well as smooth muscle on the Apoe−/− background will be performed in the future to assess the contribution of these tissues to the overall atherosclerosis protection observed after PF-06260933 treatment. The gene discussed is MAP4K4; the disease is atherosclerosis.